Saphire Lab
Erica Ollmann Saphire, Ph.D., MBA, studies, at the molecular level, how and why viruses are pathogenic. This work provides the roadmap for medical defense.
Disease Lassa Fever
LJI scientists win ‘Prebys Research Heroes’ funding
Prebys Foundation celebrates ground-breaking female researchers
Erica Ollmann Saphire wins 2023 Pantheon Award from California Life Sciences
LJI President and CEO celebrated among California’s leading life sciences innovators
Virologist Onyeka Chukwudozie wins support for international collaboration
New Merkin Fellowship to support U.K. collaboration on Lassa virus research
New Lassa fever therapy may be on the horizon
Three rare antibodies, combined in a "cocktail," are effective in fighting Lassa virus
LJI scientists discover clue to stopping Lassa virus infection
New study shows how new therapies might target Lassa and Ebola viruses
A biochemist takes on Lassa virus
Adrian Enriquez, Ph.D., has a different way of looking at viruses
Learning from men. Learning from women.
Men and women have different immune systems. With a better understanding of sex-specific immune differences, scientists can more effectively fight infections, cancers, heart disease, and even pregnancy complications.
La Jolla Institute for Immunology acquires Berkeley Lights Beacon® platform
The Beacon optofluidic technology will be used to speed the identification of lifesaving treatments for deadly viruses including Ebola, Lassa and others.
Lassa virus’ soft spot revealed
Detailed structural studies provide blueprint for the development of potent therapeutics and vaccines
La Jolla Institute-led consortium awarded up to $35 million by NIH
The grant establishes the global Viral Immunotherapeutic Consortium to develop new treatments for Ebola, Lassa and other viral threats
